ConductScience.org, home

Paper923734

Mitogenic action of neuraminidase.

Semenzato G and 3 others. Experientia, 1977. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mitogenic action of neuraminidase. Papers, record 923734. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/923734

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mitogenic action of neuraminidase.
PubMed
Journal
Experientia
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.1
iCite
Revised in PubMed
2019-06-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Semenzato GG
2Sarasin PP
3Amadori GG
4Gasparotto GG

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymphocyte ActivationMajor topic
MitogensMajor topic
NeuraminidaseMajor topic
Humans
Vibrio cholerae

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14357270Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.Blood1973https://conductscience.org/library/papers/4357270PubMed
24469229Enhancement of delayed skin hypersensitivity by neuraminidase in cancer patients.Clin Exp Immunol1974https://conductscience.org/library/papers/4469229PubMed
34162339Mitogenic action of papain.Lancet1966https://conductscience.org/library/papers/4162339PubMed
4984732[Lymphocytes HLA antigens expressivity after neuraminidase treatment (author's transl)].Ann Immunol (Paris)1976https://conductscience.org/library/papers/984732PubMed
54138857Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Report of a WHO-IARC-sponsored workshop on human B and T cells, London, 15-17 July 1974.Scand J Immunol1974https://conductscience.org/library/papers/4138857PubMed
64161182Mitogenic action of trypsin and chymotrypsin.Lancet1966https://conductscience.org/library/papers/4161182PubMed
71254945Transformation of human peripheral lymphocytes by galactose oxidase.J Immunol1976https://conductscience.org/library/papers/1254945PubMed
84122710Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells.J Exp Med1973https://conductscience.org/library/papers/4122710PubMed
95042921The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.Clin Exp Immunol1972https://conductscience.org/library/papers/5042921PubMed
104352200Neuraminidase "unmasking" and failure of trypsin to "unmask" -D-galactose-like sites on erythrocyte, lymphoma, and normal and virus-transformed fibroblast cell membranes.J Natl Cancer Inst1973https://conductscience.org/library/papers/4352200PubMed
114517665Transformation of neuraminidase-treated lymphocytes by soybean agglutinin.Proc Natl Acad Sci U S A1973https://conductscience.org/library/papers/4517665PubMed
124818458The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.J Immunol1974https://conductscience.org/library/papers/4818458PubMed
134404957The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase.Transplantation1972https://conductscience.org/library/papers/4404957PubMed
144765377Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells.J Natl Cancer Inst1973https://conductscience.org/library/papers/4765377PubMed
155062405Stimulation of DNA synthesis in mammalian cell cultures by receptor-destroying enzyme and neuraminidase.Anat Rec1972https://conductscience.org/library/papers/5062405PubMed
164110358Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures.Clin Exp Immunol1971https://conductscience.org/library/papers/4110358PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
6966605Enhancement of T-cell response to PWM by neuraminidase-treated non-T cells.Immunology1980https://conductscience.org/library/papers/6966605PubMed
431030[Glycoproteins: their biological and clinical significance. II (author's transl)].Klin Wochenschr1979https://conductscience.org/library/papers/431030PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NEU14758PubTator's text mininghttps://conductscience.org/library/genes/4758

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/923734

GET https://conductscience.org/api/papers/v1/923734/authors